These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9626777

  • 1. Magnetic resonance spectroscopy: use in monitoring MELAS treatment.
    Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O'Shea M, Lustbader D.
    Arch Neurol; 1998 Jun; 55(6):849-52. PubMed ID: 9626777
    [Abstract] [Full Text] [Related]

  • 2. Transient ischemic attack-like episodes without stroke-like lesions in MELAS.
    Mitani T, Aida N, Tomiyasu M, Wada T, Osaka H.
    Pediatr Radiol; 2013 Oct; 43(10):1400-3. PubMed ID: 23677422
    [Abstract] [Full Text] [Related]

  • 3. Carbon 13-labeled magnetic resonance spectroscopy observation of cerebral glucose metabolism: metabolism in MELAS: case report.
    Otsuki T, Kanamatsu T, Tsukada Y, Goto Y, Okamoto K, Watanabe H.
    Arch Neurol; 2005 Mar; 62(3):485-7. PubMed ID: 15767517
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies.
    Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL.
    Neurology; 1993 Dec; 43(12):2484-90. PubMed ID: 8255444
    [Abstract] [Full Text] [Related]

  • 11. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.
    Niu FN, Meng HL, Chang LL, Wu HY, Li WP, Liu RY, Wang HT, Zhang B, Xu Y.
    CNS Neurosci Ther; 2017 Aug; 23(8):686-697. PubMed ID: 28695670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recommendations for the Management of Strokelike Episodes in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes.
    Koenig MK, Emrick L, Karaa A, Korson M, Scaglia F, Parikh S, Goldstein A.
    JAMA Neurol; 2016 May 01; 73(5):591-4. PubMed ID: 26954033
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation.
    Guerrero-Molina MP, Bernabeu-Sanz Á, Ramos-González A, Morales-Conejo M, Delmiro A, Domínguez-González C, Arenas J, Martín MA, González de la Aleja J.
    Neuroradiology; 2024 Mar 01; 66(3):389-398. PubMed ID: 38114794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.